Department of Psychiatry and Behavioral Sciences, Addiction Treatment Services – BBRC, Johns Hopkins University School of Medicine, Bayview Medical Center, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA.
J Subst Abuse Treat. 2011 Dec;41(4):415-21. doi: 10.1016/j.jsat.2011.06.008. Epub 2011 Aug 9.
Poor sustained treatment engagement limits the effectiveness of all modalities of substance abuse treatment. This study evaluated the efficacy of a novel treatment reengagement intervention for a subset of syringe-exchange program (SEP) participants (N = 113) that had enrolled in treatment as part of a 4-month clinical trial (M. Kidorf et al., 2009). Three reengagement conditions for participants leaving treatment were compared. Motivational referral condition (MRC) participants (n = 31) could attend group sessions that focused on renewing treatment interest. MRC plus incentive (MRC + I) participants (n = 49) could receive modest monetary incentives for attending these sessions and reenrolling in treatment. Standard referral condition participants (n = 33) could not attend groups or receive incentives. Across a 1-year observation window, almost all study participants (86%) were discharged from treatment. MRC + I participants attended more group sessions than MRC participants and were considerably more likely to reenroll in treatment than participants in the other study conditions. Reengagement strategies can further enhance the public health benefits of SEPs by increasing rates of treatment participation over time.
治疗持续时间不足会限制所有物质滥用治疗模式的效果。这项研究评估了一种新型治疗重新参与干预对一组接受过注射器交换计划（SEP）治疗的参与者（N=113）的疗效，这些参与者在 4 个月的临床试验（M. Kidorf 等人，2009 年）中已接受治疗。对离开治疗的参与者进行了三种重新参与条件的比较。动机转介条件（MRC）参与者（n=31）可以参加关注重新治疗兴趣的小组会议。MRC 加激励（MRC+I）参与者（n=49）可以因参加这些会议和重新参加治疗而获得少量的金钱奖励。标准转介条件参与者（n=33）不能参加小组会议或获得奖励。在为期一年的观察期内，几乎所有研究参与者（86%）都已出院治疗。MRC+I 参与者参加的小组会议比 MRC 参与者多，并且重新参加治疗的可能性远高于其他研究条件的参与者。重新参与策略可以通过随着时间的推移增加治疗参与率，进一步提高 SEP 的公共卫生效益。
